Moxetumomab Pasudotox-tdfk and Naltrexone Intramuscular
Determining the interaction of Moxetumomab Pasudotox-tdfk and Naltrexone Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: naltrexone
Brand name: ReVia, Depade, Vivitrol
Synonyms: Naltrexone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Naltrexone Tablets
- Moxetumomab Pasudotox-tdfk-Namenda
- Moxetumomab Pasudotox-tdfk-Namenda (Memantine Solution)
- Moxetumomab Pasudotox-tdfk-Namenda (Memantine Tablets)
- Moxetumomab Pasudotox-tdfk-Namenda XR
- Moxetumomab Pasudotox-tdfk-Namenda XR Titration Pack
- Naltrexone Intramuscular-Moxetumomab pasudotox-tdfk Intravenous
- Naltrexone Intramuscular-Moxifloxacin
- Naltrexone Intramuscular-Moxifloxacin (Systemic)
- Naltrexone Intramuscular-Moxifloxacin Hydrochloride
- Naltrexone Intramuscular-Moxifloxacin Injection
- Naltrexone Intramuscular-Moxifloxacin Intravenous